08.01.2015 Views

Horizons Issue 3 2011 - National Gaucher Foundation

Horizons Issue 3 2011 - National Gaucher Foundation

Horizons Issue 3 2011 - National Gaucher Foundation

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

supportive but don’t want to think it could happen to them. And<br />

others don’t want to deal with it at all,” Sullivan said.<br />

“I might question them about their understanding of how they<br />

got it,” Sniderman King said. “If they don’t know, would they<br />

like to know more about it Then we can review the pattern of<br />

inheritance and what the chances are of other family members<br />

having the disease.”<br />

Creating Connections<br />

The hardest part of the work, Sullivan said, isn’t dealing with the<br />

differing family reactions, or visiting families in their homes but<br />

finding enough time to be there for everyone who needs help. – “A<br />

lot of times it just requires a lot of empathy,” she said, “sometimes<br />

putting families in touch with other families is helpful.”<br />

“The stressful part of my job is trying to have enough time for<br />

all of my patients – having enough time to reach out proactively<br />

instead of just being reactive,” Sullivan said. “It’s the geography.<br />

It is difficult to be everywhere at all times. That is our biggest<br />

downside at this point.”<br />

The satisfactions come, Sullivan said, when families find<br />

strength and solace in the information they receive, and when<br />

families meet other families who suffer from the same illness.<br />

“I want to be able to connect with everybody. Not everybody<br />

needs my services, but my goal is to help reach everyone and<br />

identify areas where I can be of help to them,” Sullivan said. “If<br />

they don’t need anything, then great. Then they know they have<br />

one more person in their corner, and who doesn’t need one more<br />

person in their corner”<br />

Patient Perspectives on Patient Education Liaisons<br />

By Cheryl Alkon<br />

Albert McWilliams<br />

Before Albert McWilliams collapsed while working as part of the maintenance<br />

crew at a local Walmart, he’d never so much as had a cold. After he<br />

collapsed, he was rushed to the hospital and learned he had a hip fracture.<br />

Albert and his wife Donna were mystified as doctors tried but failed to<br />

figure out what was wrong.<br />

McWilliams was erroneously diagnosed with backaches, muscle<br />

spasms, osteoporosis, and Paget’s disease. After a frustrating 2 years —<br />

during which he was in constant pain from the waist down, bedridden, and<br />

once begged to have his legs cut off because his pain was so severe — a<br />

doctor finally told him he had <strong>Gaucher</strong> disease type 1.<br />

But he still didn’t get the optimal care he needed right away.<br />

“We went through 3 years when we were searching for doctors that<br />

could provide the care we needed,” said Donna, now 52, his wife of 20<br />

years. “[Albert] was on half doses of Cerezyme ® (imiglucerase for injection),<br />

and a doctor tried to get him weaned off it” because the physician, at the<br />

time, didn’t understand that such therapy is lifelong.<br />

Frustrated, Donna went online to learn more as she and Albert, now 60,<br />

moved to Memphis, Tennessee. Through Genzyme’s website, Donna found a<br />

nearby doctor who was an expert in <strong>Gaucher</strong> disease type 1, and also met<br />

Marcella Lawrence, a Genzyme Patient Education Liaison (PEL) based in<br />

Tennessee. Lawrence was able to help the McWilliamses receive the care<br />

— medical and emotional — that they needed.<br />

And for the first time, Albert and Donna didn’t feel so alone.<br />

“We were invited to a Christmas party [a patient meeting organized by<br />

Lawrence and sponsored by Genzyme] and got to meet other people,” said<br />

Donna. “We had never met others with <strong>Gaucher</strong> before.”<br />

“Marcella would take the time to help us through emotionally, said Donna<br />

McWilliams.” Today, 9 years after first being diagnosed with <strong>Gaucher</strong> disease<br />

type 1, her once-bedridden husband can walk with a cane and “has a life again.”<br />

“I put out fires, and I do a lot of patient meetings,” said Lawrence, who<br />

has worked as a PEL for 7 years and oversees approximately 400 patients—<br />

including about 250 with <strong>Gaucher</strong> disease type 1—in Tennessee, Georgia,<br />

Mississippi, and Florida. “It’s the best job, because we have the luxury of<br />

working so closely with the patients. I believe it’s one of the most satisfying<br />

jobs at Genzyme.”<br />

“The amount of information she shared with us—it helped us realize<br />

we weren’t the only ones dealing with this,” said Donna McWilliams.<br />

“Seriously, we wouldn’t know what to do without Marcella.”<br />

Nancy McCorry<br />

When Nancy McCorry’s health insurance changed in 2010, she worried<br />

about how her <strong>Gaucher</strong> disease type 1 care might change. The New Jersey<br />

resident, now 45, had been receiving infusion therapy at a hospital for the<br />

prior 5 years but learned she would qualify for home care infusions with<br />

her new coverage.<br />

“When I was meeting a new nurse for the first time, I felt nervous as to<br />

how the infusion was going to go,” she said. “I wanted to be comfortable<br />

knowing she knew how to handle the medicine, how to mix it, and how<br />

to infuse it.” McCorry’s PEL, Kathleen O’Keeffe, has worked for the past<br />

5 years with approximately 300 patients in New York and New Jersey.<br />

O’Keeffe talked to the new nurse and even attended McCorry’s first home<br />

infusion visit to help oversee the process.<br />

“They [the patients] can sit with us and share their comments, concerns,<br />

and stresses,” O’Keeffe said. “We provide ongoing support to all patients<br />

that have signed HIPAA (Health Insurance Portability and Accountability<br />

Act) consent with Genzyme. We help support the management of any<br />

clinical issues and adherence to treatment recommendations. We then<br />

help facilitate this information back to the patient’s primary physician and<br />

healthcare advocates to help optimize their care.”<br />

“Kathleen was so knowledgeable, personable, and approachable, and I even<br />

learned a lot about my own disease that day,” said McCorry. “My new nurse<br />

did as well, and it was a great experience for all. After my treatment, that day,<br />

Kathleen followed up with me and gave me great comfort that I was in good<br />

hands. And almost a year later, I still love my new nurse. Kathleen was instrumental<br />

in making the transition completely seamless and nonstressful.”<br />

8 <strong>Horizons</strong> / Winter <strong>2011</strong>/2012 Please see accompanying full Prescribing Information.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!